在iSH2领域的体质PIK3R1突变可用于PI3Kα抑制
Gabriel Morin1,2,3, Alexandre P Garneau1,2, Nabiha Bouzakher1,2
1Université Paris Cité, Paris, France.
马赛克PIK3R1突变导致过度生长和血管问题. 一种PI3Kα抑制剂Alpelisib有效治疗了三名患者,减少了症状和血管形体积,没有任何不良事件.
科学领域:
- 遗传学和分子生物学
- 药理学 药理学是指药理学的学科.
- 儿科医学 儿科医学
背景情况:
- 皮克3R1突变与过度生长综合征和血管形有关.
- 这些突变导致AKT/mTOR通路的过度激活.
- 目前针对PIK3R1相关疾病的治疗方法以症状为重点,缺乏特异性.
研究的目的:
- 为了研究alpelisib在患有马赛克体质PIK3R1突变的患者中的治疗潜力.
- 评估PI3Kα抑制在该患者队列中的临床疗效和安全性.
主要方法:
- 鉴定了三名患有iSH2域中马赛克体质PIK3R1突变的患者.
- 进行了体外实验,以评估突变影响和药物敏感性.
- 在同情性使用授权下给患者服用alpelisib.
主要成果:
- 阿尔佩利西布治疗导致了快速的临床改善,包括减轻疼痛,疲劳和炎症爆发.
- 在12个月内观察到的血管形体积的平均减少为22.67%.
- 在研究期间没有报告与药物相关的不良事件.
结论:
- 用alpelisib抑制PI3Kα是一种有前途的治疗策略,用于PIK3R1相关异常.
- 阿尔佩利西布在减少症状和血管形方面表现出显著的有效性.
- 这项研究支持针对PIK3R1驱动疾病的向治疗.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
10:52Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation
Published on: January 6, 2016
相关概念视频
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
